0000315066-15-003185.txt : 20151021 0000315066-15-003185.hdr.sgml : 20151021 20151021182942 ACCESSION NUMBER: 0000315066-15-003185 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20151021 FILED AS OF DATE: 20151021 DATE AS OF CHANGE: 20151021 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dimension Therapeutics, Inc. CENTRAL INDEX KEY: 0001592288 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463942159 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-401-0011 MAIL ADDRESS: STREET 1: 840 MEMORIAL DRIVE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FMR LLC CENTRAL INDEX KEY: 0000315066 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37601 FILM NUMBER: 151168839 BUSINESS ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6175706339 MAIL ADDRESS: STREET 1: 245 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02210 FORMER NAME: FORMER CONFORMED NAME: FMR CORP DATE OF NAME CHANGE: 19920717 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2015-10-21 0 0001592288 Dimension Therapeutics, Inc. DMTX 0000315066 FMR LLC 245 SUMMER STREET BOSTON MA 02210 0 0 1 1 See Remark 1 Common Stock 239479 I Beacon Bioventures Fund III Limited Partnership Series A Preferred Stock Common Stock 5131713 I Beacon Bioventures Fund III Limited Partnership Series B Preferred Stock Common Stock 1628914 I Beacon Bioventures Fund III Limited Partnership Each share of Series A and B Preferred Stock is convertible into 0.342114 shares of Common Stock as shown in column 3 at any time at the holder's election, and automatically upon the closing of the Issuer's initial public offering, and has no expiration date. Remark 1: Edward C. Johnson 3d is a Director and the Chairman of FMR LLC and Abigail P. Johnson is a Director, the Vice Chairman, the Chief Executive Officer and the President of FMR LLC. Members of the family of Edward C. Johnson 3d, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Edward C. Johnson 3d and Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110. Remark 2: Beacon Bioventures Advisors Fund III Limited Partnership is the general partner of Beacon Bioventures Fund III Limited Partnership. Beacon Bioventures Advisors Fund III Limited Partnership is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the family of Edward C. Johnson 3d. Exhibit List: Exhibit 24 - Power of Attorney. Marc R. Bryant, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries, Edward C. Johnson 3d and Abigail P. Johnson 2015-10-21 EX-24 2 attachment1.txt EX-24 DOCUMENT Exhibit 24 POWER OF ATTORNEY WHEREAS, FMR LLC ("FMR") has appointed Scott C. Goebel, with full power of substitution, as its true and lawful attorney, with full power and authority to execute such documents and to make such regulatory or other filings and amendments thereto (the "Filings") as shall from time to time be required pursuant to the Securities Exchange Act of 1934, as amended, any rules or regulations adopted thereunder, and such other U.S. and non-U.S. laws, rules or regulations as shall from time to time be applicable in respect of the beneficial ownership of securities directly or indirectly attributable to FMR. NOW, THEREFORE, the undersigned hereby constitutes and appoints Marc R. Bryant as his substitute, to have all the powers of the undersigned with respect to the Filings, when the undersigned is unavailable. The Power of Attorney shall remain in full force and effect only for such time as the undersigned shall continue to be an officer of Fidelity Management & Research Company, provided that, notwithstanding the foregoing, this Power of Attorney may be revoked at any time by the undersigned in writing. /s/ Scott C. Goebel Scott C. Goebel Dated: October 12, 2015 POWER OF ATTORNEY WHEREAS, Edward C. Johnson 3d has appointed Scott C. Goebel, with full power of substitution, as his true and lawful attorney, with full power and authority to execute such documents and to make such regulatory or other filings and amendments thereto (the "Filings") as shall from time to time be required pursuant to the Securities Exchange Act of 1934, as amended, any rules or regulations adopted thereunder, and such other U.S. and non-U.S. laws, rules or regulations as shall from time to time be applicable in respect of the beneficial ownership of securities directly or indirectly attributable to him. NOW, THEREFORE, the undersigned hereby constitutes and appoints Marc R. Bryant as his substitute, to have all the powers of the undersigned with respect to the Filings, when the undersigned is unavailable. The Power of Attorney shall remain in full force and effect only for such time as the undersigned shall continue to be an officer of Fidelity Management & Research Company, provided that, notwithstanding the foregoing, this Power of Attorney may be revoked at any time by the undersigned in writing. /s/ Scott C. Goebel Scott C. Goebel Dated: October 12, 2015 POWER OF ATTORNEY WHEREAS, Abigail P. Johnson has appointed Scott C. Goebel, with full power of substitution, as her true and lawful attorney, with full power and authority to execute such documents and to make such regulatory or other filings and amendments thereto (the "Filings") as shall from time to time be required pursuant to the Securities Exchange Act of 1934, as amended, any rules or regulations adopted thereunder, and such other U.S. and non-U.S. laws, rules or regulations as shall from time to time be applicable in respect of the beneficial ownership of securities directly or indirectly attributable to her. NOW, THEREFORE, the undersigned hereby constitutes and appoints Marc R. Bryant as his substitute, to have all the powers of the undersigned with respect to the Filings, when the undersigned is unavailable. The Power of Attorney shall remain in full force and effect only for such time as the undersigned shall continue to be an officer of Fidelity Management & Research Company, provided that, notwithstanding the foregoing, this Power of Attorney may be revoked at any time by the undersigned in writing. /s/ Scott C. Goebel Scott C. Goebel Dated: October 12, 2015